NCT00783302View on ClinicalTrials.gov

Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care

CompletedOBSERVATIONAL
Enrollment

885

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions
Coronary Artery Disease (CAD)
Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY

NCT00783302 - Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care | Biotech Hunter | Biotech Hunter